Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Cognito Therapeutics Inc. is currently managing 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This activity is confined to 1 distinct art unit and a distinct examiner. Such a limited number of active matters suggests that the company may be in an early stage of building its portfolio or is focusing on a very specific core technology. The alignment with a single art unit provides an opportunity to master the specific examination nuances of that group without the distraction of multiple competing deadlines.
The busiest examiner for this portfolio is MALAMUD, DEBORAH LESLIE, who is responsible for the pending office action. This examiner represents the company's only current point of interaction with the patent office for pending matters. Consequently, the company's immediate patent goals are entirely dependent on the results of this examination. Developing a clear communication line with this examiner through interviews or detailed responses will be the most effective way to advance the company's current intellectual property objectives in the medical device sector.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MALAMUD, DEBORAH LESLIE | 1 | 78.2% | +9.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19292344 | METHODS AND SYSTEMS FOR NEURAL STIMULATION VIA VISUAL, AUDITORY AND PERIPHERAL NERVE STIMULATIONS | MALAMUD, DEBORAH LESLIE | 20d |
| Art Unit | Apps |
|---|---|
| 3792 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19292344 | METHODS AND SYSTEMS FOR NEURAL STIMULATION VIA VISUAL, AUDITORY AND PERIPHERAL NERVE STIMULATIONS | MALAMUD, DEBORAH LESLIE | 3792 | §102§103§112 | Final Rejection | 20d | Pending | Aug 06, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial